Oct 01, 2014 at 17:07 | Source: Moneycontrol.com
The macro story is backed by demographics, productivity and globalization implying trend growth of 6.5-7 percent. Profits are likely to gain share in GDP from their historically depressed levels, implying a CAGR of around 19 percent in the next five years.
Sep 30, 2014 at 10:44 | Source: CNBC-TV18
Yogesh Mehta of Motilal Oswal Securities is bullish on Lupin and feels that Sun Pharmaceutical Industries may test Rs 900.
Sep 30, 2014 at 10:30 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, auto stocks like Maruti Suzuki India, Bajaj Auto, TVS Motor Company and Hero Motocorp will get astro support.
Sep 30, 2014 at 10:21 | Source: CNBC-TV18
The second quarter India Inc earnings, which will kick-off from the October 10 could be a disappointment barring IT and pharma companies, Ajay Srivastava, CEO, Dimensions Consulting.
Sep 30, 2014 at 09:49 | Source: CNBC-TV18
Yogesh Mehta of Motilal Oswal Securities says in case the RBI move is positive then Nifty is likely to move towards 8100.
Sep 29, 2014 at 17:00 | Source: CNBC-TV18
Sun Pharma may not really shoot up beyond Rs 880-900 immediately but then if you are looking at long term even at these levels you should buy the stock, says Ambareesh Baliga.
Sep 29, 2014 at 15:49 | Source: CNBC-TV18
Investors have been lapping up pharma stocks in the recent few days and Sun Pharma has been one of the many beneficiaries. The stock has gained 46 percent since January 2014 (year-to-date).
Sep 29, 2014 at 15:30 | Source: CNBC-TV18
Pritesh Mehta, senior technical analyst at IIFL is of the view that Sun Pharmaceutical Industries can test Rs 890-900.
Sep 29, 2014 at 13:40 | Source: CNBC-TV18
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Sun Pharma, Thomas Cook, Cox & Kings, Valecha Engineering, Mayur Uniquoters and Strides Arcolab.
Sep 29, 2014 at 12:53 | Source: Moneycontrol.com
Sharekhan is bullish on Sun Pharmaceutical Industries and has recommended buy rating on the stock with a target of Rs 851 in its September 26, 2014 research report.